Medicines Management

Medicines management and medicines optimisation services form the basis of effective prescribing strategies in primary care; they are also fundamental elements of the services delivered by Interface Clinical Services (ICS) through our clinical pharmacist team on a daily basis.

Medicines management assesses the ways in which medicines and treatments are used by both patients and the NHS to deliver efficiencies, better outcomes and improved patient experience.

Medicines Management

Tilted Logo for Interface Clinical Services

ICS partner with NHS organisations to deliver medicines management services within a locality, CCG or practice population. Our pharmacists will deliver independent on-site clinical audits in a range of therapy areas to assist with clinical assessments, risk management and disease prevention in line with local formularies and guidelines.

Our medicines management services can be tailored to meet individual needs and specifications, with ICS able to facilitate industry funding in some cases if requested. As well as streamlining the prescribing process, our pharmacists can work with practices to offer support and educational advice to individual patients to improve compliance or optimise treatment.

In addition ICS can also implement medicines management services via our bespoke diagnostic tool, Attend2, which has been developed by our pharmacist design team and individually tailored to specific chronic diseases and long term conditions. Attend2 allows ICS to deliver medicines management service remotely, or to support the work implemented on-site by our clinical pharmacists.

The ICS pharmacist-led medicines management services empower both clinicians and patients through innovative and flexible solutions designed to optimise and improve clinical outcomes in an efficient and cost effective manner.

Case Study

Diabetes Management Initiative

ICS were commissioned by a primary care organisation to deliver a diabetes management initiative. ICS combined detailed data analysis with a patient-focussed clinical programme to review the current approach to patient self-monitoring of blood glucose levels.

Service Outcomes

  • Better patient understanding of blood glucose testing frequencies and better patient-reported quality of life scores were recorded.
  • 87% patient adherence to recommended testing frequencies (measured at audit six months post service delivery).
  • 15% of patients were able to discontinue blood glucose testing in line with national guidance.
  • 27% reduction in volume of blood glucose test strip usage.
  • 32% reduction in blood glucose testing expenditure.
  • Greater prescriber confidence was reported as a result of the rationalisation of blood glucose testing equipment in use.

This programme has been implemented in a number of primary care organisations around the UK, with outcome data from all projects delivered so far suggesting that an average-sized CCG with average diabetes prevalence can expect to save in excess of £205,000 per year from this programme.

Fill in the form below to send ICS a message, and we will get back to you as soon as possible..


I would like to receive occasional updates about ICS.